Phase 2a Trial Investigates BP Medicine SOM3355 as Treatment for Chorea
Jul 25, 2018 03:30 pm | Alice Melão
SOM3355 — a medicine approved for high blood pressure and chest pain — is being tested in a Phase 2 trial as a means to treat chorea in Huntington’s disease patients, SOM Biotech announced. The proof-of-concept study (NCT03575676) will recruit participants in four clinical sites in or near Barcelona, Spain. It is expected to include about 30 patients with […]
The post Phase 2a Trial Investigates BP Medicine SOM3355 as Treatment for Chorea appeared first on Huntington's Disease News.